ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,908Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 910

$754K Total Retail Price of All Prescriptions

Rank: 54 out of 910

988 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 988 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

6% of this provider’s 988 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,121 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 843 775 1 2
SIMVASTATIN 783 751 2 3
LEVOTHYROXINE SODIUM 734 701 3 1
AMLODIPINE BESYLATE 539 521 4 4
HYDROCHLOROTHIAZIDE 395 370 5 12
ATENOLOL 361 358 6 10
LOSARTAN POTASSIUM 258 253 7 15
METOPROLOL TARTRATE 237 231 8 7
ZOLPIDEM TARTRATE 236 236 9 17
OMEPRAZOLE 234 214 10 5
METFORMIN HCL 231 188 11 6
GABAPENTIN 230 199 12 13
LOVASTATIN 219 214 13 20
ATORVASTATIN CALCIUM 218 213 14 14
FUROSEMIDE 203 195 15 9
CITALOPRAM HBR 169 163 16 19
ALLOPURINOL 150 145 17 33
PRAVASTATIN SODIUM 148 139 18 16
FLUTICASONE PROPIONATE 138 119 19 23
WARFARIN SODIUM 136 131 20 11
PANTOPRAZOLE SODIUM 129 99 21 27
PAROXETINE HCL 127 122 22 50
TAMSULOSIN HCL 123 123 23 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 121 24 44
TRAMADOL HCL 119 106 25 25
DIOVAN 119 106 25 34
ALENDRONATE SODIUM 115 113 27 22
SPIRIVA 106 104 28 74
METFORMIN HCL ER 99 92 29 77
TRIAMTERENE-HCTZ 94 94 30 39
VENLAFAXINE HCL ER 94 78 30 115
RANITIDINE HCL 89 89 32 28
ADVAIR DISKUS 88 86 33 45
FINASTERIDE 88 88 33 59
HYDROCODONE-ACETAMINOPHEN 88 74 S3 33 8
POTASSIUM CHLORIDE 84 76 36 18
BENAZEPRIL HCL 76 72 37 89
METOPROLOL SUCCINATE 75 72 38 21
SERTRALINE HCL 73 72 39 24
DONEPEZIL HCL 68 68 40 32
CYMBALTA 68 44 40 58
AMLODIPINE BESYLATE-BENAZEPRIL 66 65 42 166
CELEBREX 65 52 43 85
CARVEDILOL 65 65 43 36
GEMFIBROZIL 64 64 45 63
CLOPIDOGREL 60 57 46 35
FELODIPINE ER 60 60 46 159
LIOTHYRONINE SODIUM 58 53 48 170
TRAZODONE HCL 56 43 49 37
SYNTHROID 56 56 49 54
OXYCODONE-ACETAMINOPHEN 55 55 S2 51 31
ESTRADIOL 55 46 R 51 92
PROPRANOLOL HCL 54 54 53 120
PROAIR HFA 51 36 54 40
FENOFIBRATE 51 46 54 55
AZITHROMYCIN 50 46 56 41
DOXAZOSIN MESYLATE 50 50 56 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.